Tag

CRDMO

1 article

Biocon Q4 FY26 Revenue Rises 10% YoY

Biocon reports Q4 FY26 revenue of ₹4,569 Cr, a 10% YoY increase, driven by 12% growth in Biosimilars. Full-year FY26 revenue grew 14% to ₹17,270 Cr, with Net Profit (before exceptions) surging 323% to